Loading organization details...
Loading organization details...
Source: IRS Form 990 via ProPublica Nonprofit Explorer
Total Revenue
▼$191.5K
Total Contributions
N/A
Total Expenses
▼$138.1K
Total Assets
$214.9K
Total Liabilities
▼$3,928
Net Assets
N/A
Officer Compensation
→N/A
Other Salaries
N/A
Investment Income
▼N/A
Fundraising
▼N/A
Source: USAspending.gov · Searched by organization name
Total Federal Funding
$10K
Awards Found
1
| Awarding Agency | Description | Amount | Fiscal Year | Period |
|---|---|---|---|---|
| Department of Health and Human Services | 2024 INTERNATIONAL COLLOQUIUM ON HYPEREMESIS GRAVIDARUM - THIS APPLICATION SEEKS FUNDING TO SUPPORT ATTENDANCE AND PRESENTATION BY THOSE WHO ARE TRAINEES, NEW INVESTIGATORS, OR UNDER-REPRESENTED MINORITIES AT THE 2024 INTERNATIONAL COLLOQUIUM ON HYPEREMESIS GRAVIDARUM. HYPEREMESIS GRAVIDARUM (HG) IS A SEVERE FORM OF NAUSEA AND VOMITING DURING PREGNANCY THAT AFFECTS APPROXIMATELY 3-10% OF PREGNANT WOMEN, LEADING TO SIGNIFICANT SHORT- AND LONG-TERM COMPLICATIONS FOR BOTH THE PREGNANT PATIENT AND FETUS. MINORITY POPULATIONS AND THEIR OFFSPRING ARE DISPROPORTIONATELY AFFECTED. THIS CONFERENCE IS DESIGNED TO FOSTER COLLABORATION BETWEEN RESEARCHERS, CLINICIANS, PATIENTS, AND PATIENT ADVOCACY GROUPS TO FURTHER OUR UNDERSTANDING AND IMPROVE THE TREATMENT OF HG. WE WILL BE HIGHLIGHTING NEW RESEARCH ON THE PATHOGENESIS OF HG WITH OPPORTUNITIES FOR TREATMENT AND PREVENTION, THE IMPACT OF MALNUTRITION AND STRATEGIES TO PREVENT IT, HG CHALLENGES IN LOW-INCOME NATIONS, THE NEED FOR FURTHER RESEARCH ON HEALTH DISPARITIES, AND IMPROVING EQUITY IN THE TREATMENT OF PATIENTS WITH HG. THIS WILL BE THE 5TH BIENNIAL INTERNATIONAL CONFERENCE ON HG, BUT THE FIRST HELD IN THE UNITED STATES. THE MEETING WILL BE HELD OVER 2 DAYS WITH MULTIPLE OPPORTUNITIES FOR ORAL AND POSTER PRESENTATIONS INCLUDING NEW INVESTIGATORS. PRIZES WILL BE AWARDED FOR THE BEST ORAL AND POSTER PRESENTATIONS BY TRAINEES. THERE WILL BE BREAKOUT SESSIONS DESIGNED TO FOSTER COLLABORATION BETWEEN EXPERIENCED RESEARCHERS AND NEW INVESTIGATORS ALONG WITH CLINICIANS AND PATIENTS. ATTENDEES AND PRESENTERS WILL BE ABLE TO APPLY FOR TRAVEL SUPPORT AND RECIPIENTS WILL BE CHOSEN BY THE ICHG SCIENTIFIC COMMITTEE BASED ON THEIR EXPRESSED NEED, CONTRIBUTION(S) TO THE MEETING, TRAINEE/NEW INVESTIGATOR STATUS, IDENTIFICATION AS A MEMBER OF AN UNDERREPRESENTED MINORITY, AND/OR INDIVIDUAL WITH A DISABILITY OR RESIDENCE IN A DEVELOPING COUNTRY. ICHG HISTORICALLY HAS A HIGH REPRESENTATION OF WOMEN AS BOTH SPEAKERS AND ATTENDEES (>50% SPEAKERS, >75% ATTENDEES). MINORITY REPRESENTATION HAS BEEN LOW, SO WE ARE STRIVING TO IMPROVE REPRESENTATION. THIS GRANT WILL HELP TO IMPROVE DIVERSITY AND SEVERAL SESSIONS WILL HELP PROMOTE MORE INCLUSIVE RESEARCH AND BETTER EQUITY IN PATIENT CARE. OUR SELECTED VENUE WILL BE COMPLIANT WITH THE AMERICANS WITH DISABILITIES ACT. THERE ARE MANY FAMILY-FRIENDLY ACTIVITIES AVAILABLE, AND CHILDCARE OPTIONS WILL BE IDENTIFIED AND DISTRIBUTED TO PARTICIPANTS. BREASTFEEDING INFANTS ARE WELCOME IN THE MEETING, AND A PRIVATE ROOM MADE AVAILABLE FOR BREASTFEEDING. THE RESULT OF THE CONFERENCE WILL BE MUCH-NEEDED PROGRESS TOWARD ADVANCING COLLABORATION, RESEARCH, EDUCATION, EQUITY, AND ULTIMATELY IMPROVED CARE AND OUTCOMES FOR THIS DEVASTATING PREGNANCY CONDITION. | $10K | FY2024 | Sep 2024 – Aug 2025 |
Department of Health and Human Services
$10K
2024 INTERNATIONAL COLLOQUIUM ON HYPEREMESIS GRAVIDARUM - THIS APPLICATION SEEKS FUNDING TO SUPPORT ATTENDANCE AND PRESENTATION BY THOSE WHO ARE TRAINEES, NEW INVESTIGATORS, OR UNDER-REPRESENTED MINORITIES AT THE 2024 INTERNATIONAL COLLOQUIUM ON HYPEREMESIS GRAVIDARUM. HYPEREMESIS GRAVIDARUM (HG) IS A SEVERE FORM OF NAUSEA AND VOMITING DURING PREGNANCY THAT AFFECTS APPROXIMATELY 3-10% OF PREGNANT WOMEN, LEADING TO SIGNIFICANT SHORT- AND LONG-TERM COMPLICATIONS FOR BOTH THE PREGNANT PATIENT AND FETUS. MINORITY POPULATIONS AND THEIR OFFSPRING ARE DISPROPORTIONATELY AFFECTED. THIS CONFERENCE IS DESIGNED TO FOSTER COLLABORATION BETWEEN RESEARCHERS, CLINICIANS, PATIENTS, AND PATIENT ADVOCACY GROUPS TO FURTHER OUR UNDERSTANDING AND IMPROVE THE TREATMENT OF HG. WE WILL BE HIGHLIGHTING NEW RESEARCH ON THE PATHOGENESIS OF HG WITH OPPORTUNITIES FOR TREATMENT AND PREVENTION, THE IMPACT OF MALNUTRITION AND STRATEGIES TO PREVENT IT, HG CHALLENGES IN LOW-INCOME NATIONS, THE NEED FOR FURTHER RESEARCH ON HEALTH DISPARITIES, AND IMPROVING EQUITY IN THE TREATMENT OF PATIENTS WITH HG. THIS WILL BE THE 5TH BIENNIAL INTERNATIONAL CONFERENCE ON HG, BUT THE FIRST HELD IN THE UNITED STATES. THE MEETING WILL BE HELD OVER 2 DAYS WITH MULTIPLE OPPORTUNITIES FOR ORAL AND POSTER PRESENTATIONS INCLUDING NEW INVESTIGATORS. PRIZES WILL BE AWARDED FOR THE BEST ORAL AND POSTER PRESENTATIONS BY TRAINEES. THERE WILL BE BREAKOUT SESSIONS DESIGNED TO FOSTER COLLABORATION BETWEEN EXPERIENCED RESEARCHERS AND NEW INVESTIGATORS ALONG WITH CLINICIANS AND PATIENTS. ATTENDEES AND PRESENTERS WILL BE ABLE TO APPLY FOR TRAVEL SUPPORT AND RECIPIENTS WILL BE CHOSEN BY THE ICHG SCIENTIFIC COMMITTEE BASED ON THEIR EXPRESSED NEED, CONTRIBUTION(S) TO THE MEETING, TRAINEE/NEW INVESTIGATOR STATUS, IDENTIFICATION AS A MEMBER OF AN UNDERREPRESENTED MINORITY, AND/OR INDIVIDUAL WITH A DISABILITY OR RESIDENCE IN A DEVELOPING COUNTRY. ICHG HISTORICALLY HAS A HIGH REPRESENTATION OF WOMEN AS BOTH SPEAKERS AND ATTENDEES (>50% SPEAKERS, >75% ATTENDEES). MINORITY REPRESENTATION HAS BEEN LOW, SO WE ARE STRIVING TO IMPROVE REPRESENTATION. THIS GRANT WILL HELP TO IMPROVE DIVERSITY AND SEVERAL SESSIONS WILL HELP PROMOTE MORE INCLUSIVE RESEARCH AND BETTER EQUITY IN PATIENT CARE. OUR SELECTED VENUE WILL BE COMPLIANT WITH THE AMERICANS WITH DISABILITIES ACT. THERE ARE MANY FAMILY-FRIENDLY ACTIVITIES AVAILABLE, AND CHILDCARE OPTIONS WILL BE IDENTIFIED AND DISTRIBUTED TO PARTICIPANTS. BREASTFEEDING INFANTS ARE WELCOME IN THE MEETING, AND A PRIVATE ROOM MADE AVAILABLE FOR BREASTFEEDING. THE RESULT OF THE CONFERENCE WILL BE MUCH-NEEDED PROGRESS TOWARD ADVANCING COLLABORATION, RESEARCH, EDUCATION, EQUITY, AND ULTIMATELY IMPROVED CARE AND OUTCOMES FOR THIS DEVASTATING PREGNANCY CONDITION.
Source: Federal Audit Clearinghouse (fac.gov)
No federal single audit records found for this organization.
Single audits are required for entities expending $750,000+ in federal awards annually.
Source: IRS e-Filed Form 990
No officer or director compensation data available for this organization.
This data is sourced from IRS Form 990, Part VII. It may not be available if the organization files Form 990-N (e-Postcard) or has not yet been enriched.
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Yes
Deductibility code: PC
WarningTax-exempt status was revoked on May 15, 2016
Reinstated on May 15, 2016
Exemption type: 03
990-N (e-Postcard) Filing History
This organization files simplified Form 990-N (annual gross receipts ≤ $50,000).
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2023 | $191.5K | — | $138.1K | $214.9K | — |
| 2022 | $115.8K | — | $129.5K | $159.9K | — |
| 2021 | $198.8K | — | $82.5K | $176K | — |
| 2020 | $97.4K | — | $90.8K | $73.3K | — |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
| Tax Year | Form Type | Source | Documents |
|---|---|---|---|
| 2024 | 990 | IRS e-File | PDF not yet published by IRSView Filing → |
| 2023 | 990-EZ | DataIRS e-File | |
| 2022 | 990-EZ | DataIRS e-File |
Financial data: IRS Form 990 via ProPublica Nonprofit Explorer (Tax Year 2023)
Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File · ProPublica Nonprofit Explorer
Tax-deductibility: IRS Publication 78
Revocation status: IRS Auto-Revocation List
| 2019 | $63.5K | — | $70.5K | $53.4K | — |
| 2021 | 990-EZ | Data |
| 2020 | 990-EZ | Data | PDF not yet published by IRS |
| 2019 | 990-EZ | Data |
| 2002 | 990-EZ | — |